JEMCX | VEMAX | JEMCX / VEMAX | |
Total Expense Ratio | 1.74 | 0.13 | 1,338% |
Annual Report Gross Expense Ratio | 1.82 | 0.13 | 1,400% |
Fund Existence | 20 years | 19 years | - |
Gain YTD | 30.504 | 21.144 | 144% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | 1000 | N/A | - |
Net Assets | 9.13B | 130B | 7% |
Annual Yield % from dividends | 0.45 | 2.65 | 17% |
Returns for 1 year | 20.48 | 13.70 | 150% |
Returns for 3 years | 55.44 | 53.21 | 104% |
Returns for 5 years | 11.58 | 38.74 | 30% |
Returns for 10 years | 114.99 | 93.76 | 123% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FTXH | 27.67 | 0.37 | +1.35% |
First Trust Nasdaq Pharmaceuticals ETF | |||
RSPG | 81.56 | 0.99 | +1.23% |
Invesco S&P 500® Equal Weight Energy ETF | |||
GSUS | 91.83 | 0.53 | +0.58% |
Goldman Sachs MarketBeta US Equity ETF | |||
EVIM | 52.51 | 0.02 | +0.03% |
Eaton Vance Intermediate Muncpl Inc ETF | |||
EBIT | 33.93 | N/A | N/A |
Harbor AlphaEdge Small Cap Earners ETF |